ERA-NET PathoGenoMics M. Karrasch, FZJ rd Network Steering Committee Meeting 5th Executing Board Meeting Workshop of Common Understanding 26th-27th September, Helsinki (-> Agenda) Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics - Joint Secretariat

ERA-NET PathoGenoMics M. Karrasch, FZJ News 2.Workplan 3.Deliverables and Milestones 4.Financial Summary

ERA-NET PathoGenoMics M. Karrasch, FZJ Uptake of the two new Hungarian Partners: Partner 12: HAS (Hungarian Academy of Sciences) -> NSC member: Prof. Bela Nagy -> Contact person: Dr. György Schneider Partner 13: OTKA (Hungarian Scientific Research Fund)

ERA-NET PathoGenoMics M. Karrasch, FZJ PathoGenoMics brochure is now available

ERA-NET PathoGenoMics M. Karrasch, FZJ News 2.Workplan 3.Deliverables and Milestones 4.Financial Summary

ERA-NET PathoGenoMics M. Karrasch, FZJ WP 7 development of the admin. framework + Application/ evaluation system WP 6 working group „training issues“ WP 4 SMEs/industry working group WP 9 science and society: communication platform WP 6 development of transnational research consortia WP 3 development of a „strategic Research Agenda“ 12/ Agree ment about SRA 9/2005 Agreement about admin. framework and appl./ eval. system 4/ WP 8 1st joint call WP 8 Project execution WP 8 2nd joint call Partne- ring Event /2004 Start WP information exchange about the national programmes Commitment of the partners regarding joint call

ERA-NET PathoGenoMics M. Karrasch, FZJ / WP 8 1st joint call WP 8 Project execution /2004 Start Germany 12/04 Spain 01/05 Austria 01/05 Slovenia 04/05 Finland 05/05 France 05/05 Israel 07/05 Portugal 08/05

ERA-NET PathoGenoMics M. Karrasch, FZJ Expected framework for the first joint call: 4 documents  Announcement: - english version: „skeleton“ for the national announcements; defines research topics, application/evaluation procedure etc. - specifically adapted/supplemented national versions; to be published at the same time (December 2005) in all participating countries  IPR issues: „ Information for applicants for project funding drawing up cooperation agreements on collaborative projects”  Programme/Project management description (internal document)  Guideline for evaluators √ √

ERA-NET PathoGenoMics M. Karrasch, FZJ News 2.Workplan 3.Deliverables and Milestones 4.Financial Summary

ERA-NET PathoGenoMics M. Karrasch, FZJ Month Timetable Deliverables: due dates D 1.1D 1.2D 1.3 D 2.1, 2.2, 2.3 D 3.1 D 4.1 D 5.1 D 6.1 D 6.2 D 7.1, 7.2, 7.3 D 8.1 D 9.1, 9.2 D 10.1, 10.2 D 2.4 D 3.2 D 3.3 D 4.2, 4.3 D 5.2 D 7.4 D 8.1 D 8.2 D 8.3, 8.4D 8.3D 8.4 D 9.2 D 10.4 D 10.3 D 10.5

ERA-NET PathoGenoMics M. Karrasch, FZJ Month D 1.1 Timetable Deliverables: completion dates D 1.2D 1.3 D 2.1, 2.2, 2.3 D 3.1 D 6.1 D 6.2 D 7.1, 7.2, 7.3 D 8.1 D 9.1, 9.2 D 10.1, 10.2 D 2.4 D D 3.3 D 5.2 D 7.4 D 8.1 D 8.2 D 8.3, 8.4D 8.3D 8.4 D 9.3 D 10.4 D 10.3 D 10.5 D 4.1 D 4.2, 4.3 D 5.1 D 3.3 D 9.3

ERA-NET PathoGenoMics M. Karrasch, FZJ Month WP 10: M1 Constituent Assembly WP 2: M2 Memorandum of Common Understanding WP 4: M3 Jointly agreed innovation paper WP 7: M4 Legal and contractual framework WP 6: M5 European training agenda WP 4: M6 European research agenda WP 8: M7a Contracts 1st round WP 8: M7b Contracts 2nd round Timetable Milestones

ERA-NET PathoGenoMics M. Karrasch, FZJ News 2.Workplan 3.Deliverables and Milestones 4.Financial Summary

ERA-NET PathoGenoMics M. Karrasch, FZJ months 0 Budget Cumulative costs per month and average (€) Estimated based on the costs of AT, FI, DE, IL

ERA-NET PathoGenoMics M. Karrasch, FZJ Budget and costs (€) months 0 Estimated based on the costs of AT, FI, DE, IL, LV and ES

ERA-NET PathoGenoMics M. Karrasch, FZJ

ERA-NET PathoGenoMics M. Karrasch, FZJ Month D 1.1 Timetable Deliverables: completion dates D 1.2D 1.3 D 2.1, 2.2, 2.3 D 3.1 D 6.1 D 6.2 D 7.1, 7.2, 7.3 D 8.1 D 9.1, 9.2 D 10.1, 10.2 D 2.4 D 3.2 D 3.3 D 5.2 D 7.4 D 8.1 D 8.2 D 8.3, 8.4D 8.3D 8.4 D 9.3 D 10.4 D 10.3 D 10.5 D 4.1 D 4.2, 4.3 D 5.1 D 3.3 back D 3.2: Minutes from expert workshop 1 per session (Paris, May 05) Due date: Completion date: MM 13 D 3.3: European Research Agenda 1. published draft 2. final version Due dates: MM 15 Approx. Completion dates: 1. MM 13 ? 2. MM 17 ? MM 9 MM 11 D 9.3

ERA-NET PathoGenoMics M. Karrasch, FZJ Month D 1.1 Timetable Deliverables: completion dates D 1.2D 1.3 D 2.1, 2.2, 2.3 D 3.1 D 6.1 D 6.2 D 7.1, 7.2, 7.3 D 8.1 D 9.1, 9.2 D 10.1, 10.2 D 2.4 D D 3.3 D 5.2 D 7.4 D 8.1 D 8.2 D 8.3, 8.4D 8.3D 8.4 D 9.3 D 10.4 D 10.3 D 10.5 D 5.1 D 3.3 Deliv. No Deliverable nameDue date (DoW) Current status Approx. Comple- tion D 4.1Strategy paper “Innovation potentials & perspectives in pathogenomics” MM 131st presentation planned in MM 13 MM 17 D 4.2Supporting network of innovation partners (PIPs) incl. minutes of 5 annual meetings (MM 15, 24, 36, 48, 60) MM 151st PIP meeting planned for MM 17 MM 17 D 4.3Web-based innovation market (including multiplication system) MM 15Will be delayed due to delay in D 4.1 and 4.2 back D 4.1 D 4.2, 4.3 WP 4: Stimulating the environment for a wider exploitation and job creation

ERA-NET PathoGenoMics M. Karrasch, FZJ Month D 1.1 Timetable Deliverables: completion dates D 1.2D 1.3 D 2.1, 2.2, 2.3 D 3.1 D 6.1 D 6.2 D 7.1, 7.2, 7.3 D 8.1 D 9.1, 9.2 D 10.1, 10.2 D 2.4 D D 3.3 D 5.2 D 7.4 D 8.1 D 8.2 D 8.3, 8.4D 8.3D 8.4 D 9.3 D 10.4 D 10.3 D 10.5 D 4.1 D 4.2, 4.3 D 5.1 D 3.3 D 5.1: Partnering workshop in Helsinki Due date: MM 13 current status: Planned for Feb. 06 in collaboration with NoE “EuroPathogenomics”; approx. 2 months after call publication; probably not in Helsinki back D 9.3

ERA-NET PathoGenoMics M. Karrasch, FZJ Month D 1.1 Timetable Deliverables: completion dates D 1.2D 1.3 D 2.1, 2.2, 2.3 D 3.1 D 6.1 D 6.2 D 7.1, 7.2, 7.3 D 8.1 D 9.1, 9.2 D 10.1, 10.2 D 2.4 D D 3.3 D 5.2 D 7.4 D 8.1 D 8.2 D 8.3, 8.4D 8.3D 8.4 D 9.3 D 10.4 D 10.3 D 10.5 D 4.1 D 4.2, 4.3 D 5.1 D 3.3 back D 9.1: IT-based communication and information platform (with media service, archive, event calendars, etc.) Due date: MM 9 current status: PathoGenoMics web pages publicly accessible since 10th of October Communication and information platform is being programmed at the moment; will presumably be available in September 2005 D 9.2: Printed information material (e.g. teaching aids, annual reports, brochures, leaflets) Due date: MM 9 Current status: First brochure about the PathoGenoMics ERA-NET is available in August 2005

ERA-NET PathoGenoMics M. Karrasch, FZJ Month D 1.1 Timetable Deliverables: completion dates D 1.2D 1.3 D 2.1, 2.2, 2.3 D 3.1 D 6.1 D 6.2 D 7.1, 7.2, 7.3 D 8.1 D 9.1, 9.2 D 10.1, 10.2 D 2.4 D D 3.3 D 5.2 D 7.4 D 8.1 D 8.2 D 8.3, 8.4D 8.3D 8.4 D 9.3 D 10.4 D 10.3 D 10.5 D 4.1 D 4.2, 4.3 D 5.1 D 3.3 D 9.3 back D 9.3: On-spot presentations (annually, at special events) Due dates: MM 10, 19, 32, 43, 55) Completion dates: ?

ERA-NET PathoGenoMics M. Karrasch, FZJ Deliv.NoDeliverable nameDue date (DoW) Current statusApprox. Comple- tion D 4.1Strategy paper “Innovation potentials & perspectives in pathogenomics” MM 131st presentation planned in MM13 MM 17 D 4.2Supporting network of innovation partners (PIPs) incl. minutes of 5 annual meetings (MM 15, 24, 36, 48, 60) MM 151st PIP meeting planned for MM 17 MM 17 D 4.3Web-based innovation market (including multiplication system) MM 15Will be delayed due to delay in D 4.1 and 4.2 back

ERA-NET PathoGenoMics M. Karrasch, FZJ Deliv. No Deliverable nameDue date (DoW) Current statusApprox. Compl e-tion Submi ssion to EC D 5.1Partnering workshop in Helsinki (about 200 persons, 2 days) MM 13Planned for Feb. 06 in collaboration with NoE “EuroPatho- genomics”; approx. 2 months after call publication; probably not in helsinki MM 17 back

ERA-NET PathoGenoMics M. Karrasch, FZJ Deliv. No Deliverable nameDue date (DoW) Current statusComple- tion Submission to EC D 1.1Agreement on programme data to be collected incl. standard format for data exchange/processing MM 1completedMM 3MM 7 (1 st Mar 2005) D. 1.2Information documents on the national programmes (one per partner) MM 5completedMM 7MM 12 (16 th Aug 2005) D 1.3Interactive Information System on Pathogenomics (IISP) MM 9completedMM 2 MM 11 MM 12 (16 th Aug 2005) D 2.1Documentations to national programmes in third countries MM 5completedMM 7MM 12 (16 th Aug 2005) D 2.2Compilation of international cooperations between European and third countries MM 5completedMM 7MM 12 (16 th Aug 2005) D 2.3Report “Future trends & challenges in pathogenomics“ (as result of a foresight study) MM 5completedMM 7MM 12 (16 th Aug 2005) D 2.4Workshop for common understanding plus related printed information materials (brochures, leaflets) MM 6completedMM 8MM 12 (16 th Aug 2005) D 3.1Minutes from “kick-off” starting meeting MM 7completedMM 8MM 12 (16 th Aug 2005) D 3.2Minutes from expert workshops (one per session) MM 9workshop took place 23 rd to 25 th of May 2005 in Paris; Minutes will be delivered by P5 (MRNT), France, approx. in xx 2005 MM 12 D 3.3European Research Agenda (1. published draft, 2. final version) MM 11, 15MM 11

ERA-NET PathoGenoMics M. Karrasch, FZJ Deliv.No Deliverable nameDue date (DoW) Current statusApprox. Comple- tion Submis sion to EC D 4.1Strategy paper “Innovation potentials & perspectives in pathogenomics” MM 131st presentation planned in MM13 MM 17 D 4.2Supporting network of innovation partners (PIPs) incl. minutes of 5 annual meetings (MM 15, 24, 36, 48, 60) MM 151st PIP meeting planned for MM 17 MM 17 D 4.3Web-based innovation market (including multiplication system) MM 15Will be delayed due to delay in D 4.1 and 4.2 D 5.1Partnering workshop in Helsinki (about 200 persons, 2 days) MM 13Planned for Feb. 06 with NoE MM 17 D 5.2Satellite workshop to 2 nd FEMS conference in Spain (July 2006, about 200 persons, 1 day) MM 23 D 6.1Summer schools, transnational Ph.D. supervision, joint seminars, and other specific training measures From MM 13 D 6.2Integration of PathoGenoMics at the European Researchers Mobility Portal MM 15 D 7.1Guidelines for proposers and evaluators; joint evaluation system including administration tools MM 13 D 7.2Transnational expert/adviser databaseMM 13 D 7.3Legal and contractual framework (i.e. contract, cooperation agreement, funding scheme) MM 13Agreement on 3rd NSC meeting planned MM 13 D 7.4Transnational task force of programme managersfrom MM 14See D 7.3MM 13

ERA-NET PathoGenoMics M. Karrasch, FZJ Deliv.No Deliverable nameDue date (DoW) Current statusApprox. Comple- tion D 8.1Publication of 2 synchronised, specific transnational calls MM 16, 28Publication of the first joint call scheduled for December 2005 MM 16 D 8.22 evaluation sessions incl. priority lists MM 22, 34Deadline for proposal submission scheduled for April 2006, evaluation will take place April to June 2006 MM 22 D 8.3Selected proposals and funding contracts MM 24, 36Funding decision scheduled for July 2006MM 3 D 8.4Periodical project reports (annually) MM 36, 48, 60 D 9.1IT-based communication and information platform (with media service, archive, event calendars, etc.) MM 9PathoGenoMics web pages publicly accessible since 10 th of October Communication and information platform is programmed at the moment; will presumably be available in September 2005 D 9.2Printed information materials (i.e. teaching aids, annual reports, brochures, leaflets) MM 9First brochure about the PathoGenoMics ERA-NET is available in August 2005 D 9.3On-spot presentations (annually, at special events) MM 10, 19, 32, 43, 55

ERA-NET PathoGenoMics M. Karrasch, FZJ Deliv. No Deliverable name Due date Current statusComple -tion Submission to EC D 10.1Joint SecretariatMM 4Joint Secretariat was established on 1 st of September MM 1MM 3 (15 th Nov 2004) D 10.2Electronic Management and Information System MM 4PathoGenoMics web pages publicly accessible since 10 th of October Web-based management- and information tool available since 25 th of February, 2005 MM 2 MM 6 MM 7 (1 st Mar 2005) D 10.3Consortium management reporting (progress and financial reports, audit certificates) MM 12, 24, 36, 48, 60 Consortium management reporting submitted 11/04, 03/05, 08/05 Financial report and audit certificates due in MM 18, 36 and 60 MM 2, MM 7, MM 12 D 10.4Consortium agreement MM 1The signed Agreements were returned to the Coordinator between November 2004 and February 2005 (last Agreement arrived on 21 st February at the Coordinator) (except Hungary) MM 6MM 7 (1 st Mar 2005) D 10.5NSC and EB meetings incl. quarterly circulars MM 1, 3, 6, 9, 12,..., 60 The 1 st NSC meeting and the 1 st EB meeting: 13 th – 15 th October 2004 in Berlin The 2 nd EB meeting: 20 th January in Bonn, Germany The 3 rd EB/ 2 nd NSC meeting: 7 th /8 th of April in Bonn, Germany The 4 th EB meeting: 27 th /28 th of June in Vienna, Austria The 5 th EB/ 3 rd NSC meeting: 26 th /27 th of September in Helsinki, Finland MM 2 MM 5 MM 8 MM 10 MM 3 (15 th Nov 2004) MM 7 (1 st Mar 2005) MM 12 (16 th Aug 2005) MM 12 (16 th Aug 2005)

ERA-NET PathoGenoMics M. Karrasch, FZJ YearDue Mon th Num ber SpecificationCurrent statusApprox. completion Submission to EC 1MM 1M 1Constituent Assembly to establish project bodies Constituent Assembly held on 13 th to 15 th October 2004 in Berlin, Project Bodies have been established Completed MM 2 MM 3 (15 th Nov 2004) MM 6M 2Memorandum of Common Understanding Completed on the NSC/EB meeting on the 7 th and 8 th April 2005 in Bonn Completed MM 8 MM 12 (16 th August 2005) 2MM 13 M 3jointly agreed Innovation Strategy Paper MM 18 MM 13 M 4jointly agreed Legal & Contractual Framework for Joint Calls MM 13 M 5jointly agreed European Training Agenda MM 13 MM 15 M 6Jointly agreed European Research Agenda MM 13 MM 24 M 7aContracts, 1 st round of Joint Calls MM 22 3MM 36 M 7bContracts, 2 nd round of Joint Calls MM 34 Milestones

ERA-NET PathoGenoMics M. Karrasch, FZJ Agenda September 26-27, 2005 Helsinki, Finland. back

ERA-NET PathoGenoMics M. Karrasch, FZJ Agenda September 26-27, 2005 Helsinki, Finland